| Literature DB >> 34349165 |
Christoph Zenzmaier1, Jessie Janssen2, Christoph Zulmin3, Philipp Österreicher2, Lea Heinrich3, Gerhard Tucek2, Susanne Perkhofer4.
Abstract
Empathy is a multifaceted phenomenon that is difficult to measure. Self-report questionnaires are the most common and well-validated measures while currently no validated protein biomarkers associated with the empathic reaction have been established. Trigger films have been previously used in psychological research to evoke emotions. Thus, in the present randomized cross-over study we investigated the responses of nine salivary biomarkers that have been related to emotions and stress following an empathy triggering and a control film sequence. Additionally, questionnaires for empathy (Saarbrucken Personality Questionnaire (SPQ)) and current mental stress were applied and participants were asked to assess the film protagonists' emotions using the Positive and Negative Affect Schedule. Data from 46 participants were included in the analysis. α-Amylase, IgA, IL-1β and estradiol showed a significantly different response between the empathy and control intervention. Moreover, normalized levels of these biomarkers significantly correlated with single scales of the SPQ (control film sequence: α-amylase and IgA with personal distress; estradiol with empathic concern; IL-1β with fantasy; empathy triggering film sequence: IgA with empathic concern, fantasy and the total empathy score). These findings indicated that the observed changes in salivary biomarker levels were reflective of a physiological response to the empathy triggering film sequence. Future studies using different triggers and settings will show if the identified biomarkers can be considered as surrogate markers for empathic reactions in general.Entities:
Year: 2021 PMID: 34349165 PMCID: PMC8338960 DOI: 10.1038/s41598-021-95337-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic presentation of data collection sessions. STAI State-Trait Anxiety Inventory, VAS visual analogue scale, PANAS Positive and Negative Affect Schedule, SPQ Saarbrucken Personality Questionnaire.
Participants’ age, trait anxiety and trait empathy as determined by SPQ (n = 46).
| Median | (IQR) | |
|---|---|---|
| Age [yrs] | 27.5 | (23, 36.25) |
| Trait anxiety | 39 | (33, 41.25) |
| EC | 16 | (15, 18) |
| FS | 15 | (13.75, 17) |
| PD | 11 | (9.75, 12.25) |
| PT | 16 | (15, 17) |
| E | 47 | (45, 51) |
SPQ Saarbrucken Personality Questionnaire, EC empathic concern, FS fantasy, PD personal distress, PT perspective taking, E empathy score (= EC + FS + PT).
Self-reported stress pre, and empathy post empathy trigger or control film sequence.
| Control | Empathy | ||||
|---|---|---|---|---|---|
| Median | (IQR) | Median | (IQR) | ||
| STAI state | 36 | (33, 40.25) | 36 | (32, 43.5) | 0.147 |
| Stress VAS [mm] | 25 | (18.75, 41.5) | 30 | (18.75, 54.5) | 0.061 |
| PANAS PA | 42 | (37.75, 44) | 25 | (22, 29) | < 0.001 |
| PANAS NA | 14.5 | (12, 17) | 34 | (30, 38.25) | < 0.001 |
| Empathy VAS [mm] | 70.5 | (59.5, 80.5) | 84.5 | (75.75, 91.25) | < 0.001 |
*Wilcoxon signed-rank test.
Biomarker level pre (time point 1), and post (time points 2 and 3) empathy trigger or control film sequence.
| Intervention | Time point 1 | Time point 2 | Time point 3 | ||||
|---|---|---|---|---|---|---|---|
| Median | (IQR) | Median | (IQR) | Median | (IQR) | ||
| α-Amylase | Control | 197 | (134, 275) | 176 | (144, 283) | 178* | (136, 254) |
| [U/mL] | Empathy | 183 | (128, 283) | 198 | (137, 287) | 200 | (139, 283) |
| Androstendione | Control | 100 | (61, 170) | 96 | (68, 162) | 114 | (67, 164) |
| [pg/mL] | Empathy | 107 | (61, 141) | 110 | (66, 156) | 114 | (51, 171) |
| Cortisol | Control | 2.1 | (1.6, 3.3) | 1.9** | (1.4, 3.1) | 1.7** | (1.3, 3.1) |
| [ng/mL] | Empathy | 1.9 | (1.4, 4.1) | 2.1* | (1.6, 3.6) | 2.3* | (1.6, 3.4) |
| DHEA | Control | 146 | (77, 252) | 154 | (78, 243) | 146 | (79, 259) |
| [pg/mL] | Empathy | 154 | (70, 215) | 130 | (90, 223) | 138 | (75, 210) |
| Estradiol | Control | 5.7 | (3.0, 8.6) | 7.2** | (3.7, 10.8) | 6.9* | (3.4, 11.2) |
| [pg/mL] | Empathy | 5.1 | (1.8, 7.9) | 6.1** | (2.9, 9.9) | 6.9** | (3.4, 10.2) |
| IgA | Control | 22.2 | (12.6, 30.2) | 21.6 | (15.0, 32.9) | 23.7 | (15.4, 34.6) |
| [µg/mL] | Empathy | 26.5 | (18.5, 40.2) | 21.2** | (13.6, 33.4) | 22.1** | (13.3, 33.6) |
| IL-1β | Control | 26.7 | (17.6, 70.1) | 33.4 | (17.2, 67.6) | 28.8 | (19.0, 63.1) |
| [pg/mL] | Empathy | 33.4 | (15.6, 91.6) | 26.6 | (12.1, 82.3) | 25.4 | (12.6, 83.3) |
| IL-8 | Control | 14.3 | (5.3, 148.7) | 12.2 | (7.1, 191.6) | 15.6 | (6.7, 107.4) |
| [pg/mL] | Empathy | 20.2 | (8.0, 152.5) | 17.3 | (7.2, 150.6) | 15.6 | (6.8, 135.0) |
| Testosterone | Control | 45.9 | (13.7, 75.3) | 42.2 | (19.4, 81.2) | 47.2** | (18.3, 86.8) |
| [pg/mL] | Empathy | 28.6 | (11.9, 72.1) | 34.9 | (13.4, 76.4) | 47.9** | (13.0, 90.7) |
Wilcoxon signed-rank Test; *P < 0.05; **P < 0.01 compared with time point 1.
Biomarker levels post empathy trigger or control film sequence normalized to time point 1.
| Control | Empathy | |||||
|---|---|---|---|---|---|---|
| Median | (IQR) | Median | (IQR) | |||
| α-Amylase | Δ2-1 | 1.2 | (− 21.1, 15.1) | 7.6 | (− 19.0, 35.1) | 0.105 |
| [U/mL] | Δ3-1 | − 6.1 | (− 39.3, 10.0) | 4.1 | (− 16.6, 23.3) | 0.042 |
| Androstendione | Δ2-1 | 3.3 | (− 12.4, 17.2) | 0.4 | (− 11.3, 15.4) | 0.961 |
| [pg/mL] | Δ3-1 | 8.3 | (− 13.2, 32.7) | 7.3 | (− 20.8, 55.0) | 0.739 |
| Cortisol | Δ2-1 | − 0.1 | (− 0.6, 0.1) | − 0.2 | (− 0.4, 0.2) | 0.397 |
| [ng/mL] | Δ3-1 | − 0.3 | (− 0.8, 0.1) | − 0.3 | (− 1.0, 0.3) | 0.996 |
| DHEA | Δ2-1 | 1.6 | (− 18.5, 21.3) | − 0.7 | (− 28.0, 16.9) | 0.623 |
| [pg/mL] | Δ3-1 | 3.8 | (− 22.1, 57.1) | − 1.8 | (− 31.2, 25.3) | 0.050 |
| Estradiol | Δ2-1 | 0.9 | (− 0.2, 2.2) | 1.0 | (0.1, 2.0) | 0.495 |
| [pg/mL] | Δ3-1 | 0.2 | (− 0.5, 2.0) | 1.5 | (0.5, 2.9) | 0.023 |
| IgA | Δ2-1 | 0.5 | (− 2.2, 5.9) | − 3.4 | (− 10.6, 0.7) | 0.003 |
| [µg/mL] | Δ3-1 | 1.8 | (− 2.0, 6.5) | − 3.0 | (− 9, − 0.8) | < 0.001 |
| IL-1β | Δ2-1 | 1.0 | (− 8.7, 11.9) | − 2.3 | (− 20.7, 4.0) | 0.004 |
| [pg/mL] | Δ3-1 | − 1.9 | (− 8.7, 8.0) | − 3.9 | (− 16.1, 5.1) | 0.117 |
| IL-8 | Δ2-1 | 0.0 | (− 2.8, 5.7) | 1.6 | (− 6.2, 10.7) | 0.882 |
| [pg/mL] | Δ3-1 | − 0.5 | (− 4.5, 7.0) | − 1.6 | (− 15.1, 3.2) | 0.134 |
| Testosterone | Δ2-1 | 2.7 | (− 1.6, 7.4) | 1.5 | (− 1.2, 8.1) | 0.573 |
| [pg/mL] | Δ3-1 | 3.9 | (− 0.2, 13.1) | 4.0 | (− 0.5, 13.9) | 0.851 |
Δ2-1…normalized biomarker level at time point 2 (level time point 2 – level time point 1); Δ3-1…normalized biomarker level at time point 3 (level time point 3 – level time point 1); *Wilcoxon signed-rank test.
Figure 2Normalized salivary biomarker levels post empathy trigger or control film sequence. Normalized salivary levels of α-amylase, IgA, estradiol and IL-1β at time point 2 (Δ2-1) and time point 2 (Δ3-1) post empathy trigger or control film sequence. Statistical significance determined by Wilcoxon signed-rank test. *P < 0.05; **P < 0.01.
Spearman correlation between trait empathy as determined by SPQ and normalized salivary biomarker levels.
| α-Amylase | Estradiol | IgA | IL-1β | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | Empathy | Control | Empathy | Control | Empathy | Control | Empathy | ||||||||||
| Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | Δ2-1 | Δ3-1 | ||
| EC | CC | .278 | .204 | .084 | .208 | − .196 | .001 | − .067 | − .127 | − .162 | − .070 | − .147 | .122 | − .047 | − .102 | ||
| FS | CC | .210 | .005 | .050 | .318* | − .178 | − .276 | − .158 | .319* | .010 | − .002 | − .133 | − .187 | − .185 | .302* | ||
| PD | CC | − .212 | − .063 | − .053 | − .137 | − .014 | − .231 | − .128 | − .104 | .140 | .165 | − .203 | − .175 | ||||
| PT | CC | .122 | .080 | .075 | .151 | .312* | .043 | − .118 | − .176 | .142 | .082 | .075 | − .075 | .016 | .043 | .219 | .247 |
| E | CC | .291 | .089 | .149 | .376* | − .019 | − .278 | − .110 | − .246 | − .027 | − .079 | − .007 | − .221 | − .016 | .026 | − .018 | |
EC empathic concern, FS fantasy, PD personal distress, PT perspective taking, E empathy score (= EC + FS + PT), CC correlation coefficient, Sig significance; *significance level 0.05; **significance level 0.01. CCs with P < 0.01 were highlighted in bold.